INTCHAINS GROUP LTD-ADR (ICG) Fundamental Analysis & Valuation

NASDAQ:ICG • US45828E1047

1.2298 USD
-0.02 (-1.62%)
Last: Mar 12, 2026, 04:30 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This ICG fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

ICG gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 115 industry peers in the Semiconductors & Semiconductor Equipment industry. No worries on liquidiy or solvency for ICG as it has an excellent financial health rating, but there are worries on the profitability. ICG does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

3

1. ICG Profitability Analysis

1.1 Basic Checks

  • In the past year ICG was profitable.
  • The reported net income has been mixed in the past 5 years: ICG reported negative net income in multiple years.
  • The reported operating cash flow has been mixed in the past 5 years: ICG reported negative operating cash flow in multiple years.
ICG Yearly Net Income VS EBIT VS OCF VS FCFICG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M 400M

1.2 Ratios

  • ICG's Return On Assets of 8.02% is fine compared to the rest of the industry. ICG outperforms 78.26% of its industry peers.
  • ICG has a better Return On Equity (8.31%) than 69.57% of its industry peers.
Industry RankSector Rank
ROA 8.02%
ROE 8.31%
ROIC N/A
ROA(3y)13.09%
ROA(5y)26.31%
ROE(3y)13.44%
ROE(5y)28.42%
ROIC(3y)N/A
ROIC(5y)N/A
ICG Yearly ROA, ROE, ROICICG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

1.3 Margins

  • With an excellent Profit Margin value of 35.44%, ICG belongs to the best of the industry, outperforming 93.04% of the companies in the same industry.
  • In the last couple of years the Profit Margin of ICG has declined.
  • In the last couple of years the Operating Margin of ICG has declined.
  • ICG has a Gross Margin (36.93%) which is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of ICG has grown nicely.
Industry RankSector Rank
OM N/A
PM (TTM) 35.44%
GM 36.93%
OM growth 3Y-74.9%
OM growth 5YN/A
PM growth 3Y-36.46%
PM growth 5YN/A
GM growth 3Y-13.15%
GM growth 5Y25.4%
ICG Yearly Profit, Operating, Gross MarginsICG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. ICG Health Analysis

2.1 Basic Checks

  • ICG does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • ICG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ICG Yearly Shares OutstandingICG Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
ICG Yearly Total Debt VS Total AssetsICG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • An Altman-Z score of 9.64 indicates that ICG is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 9.64, ICG is in the better half of the industry, outperforming 69.57% of the companies in the same industry.
  • ICG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 9.64
ROIC/WACCN/A
WACC10.11%
ICG Yearly LT Debt VS Equity VS FCFICG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • ICG has a Current Ratio of 16.53. This indicates that ICG is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 16.53, ICG belongs to the top of the industry, outperforming 96.52% of the companies in the same industry.
  • ICG has a Quick Ratio of 13.29. This indicates that ICG is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of ICG (13.29) is better than 96.52% of its industry peers.
Industry RankSector Rank
Current Ratio 16.53
Quick Ratio 13.29
ICG Yearly Current Assets VS Current LiabilitesICG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. ICG Growth Analysis

3.1 Past

  • ICG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -46.15%.
EPS 1Y (TTM)-46.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-850%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-49.15%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y45.31%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year75.98%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ICG Yearly Revenue VS EstimatesICG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M
ICG Yearly EPS VS EstimatesICG Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 0.02 0.04 0.06 0.08 0.1

More info and screens

Find the best growth stocksShow best growing peers

0

4. ICG Valuation Analysis

4.1 Price/Earnings Ratio

  • ICG is valuated quite expensively with a Price/Earnings ratio of 122.98.
  • The rest of the industry has a similar Price/Earnings ratio as ICG.
  • ICG's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.15.
  • The Price/Forward Earnings ratio is 83.02, which means the current valuation is very expensive for ICG.
  • Based on the Price/Forward Earnings ratio, ICG is valued a bit more expensive than 61.74% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.27, ICG is valued quite expensively.
Industry RankSector Rank
PE 122.98
Fwd PE 83.02
ICG Price Earnings VS Forward Price EarningsICG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ICG Per share dataICG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)2.71
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ICG Dividend Analysis

5.1 Amount

  • ICG does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ICG Fundamentals: All Metrics, Ratios and Statistics

INTCHAINS GROUP LTD-ADR

NASDAQ:ICG (3/12/2026, 4:30:02 PM)

1.2298

-0.02 (-1.62%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)02-26
Earnings (Next)N/A
Inst Owners0.51%
Inst Owner Change132.27%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap74.24M
Revenue(TTM)N/A
Net Income(TTM)91.69M
Analysts80
Price Target3.57 (190.29%)
Short Float %0.93%
Short Ratio2.65
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)774.98%
Min EPS beat(2)42.23%
Max EPS beat(2)1507.72%
EPS beat(4)2
Avg EPS beat(4)338.39%
Min EPS beat(4)-136%
Max EPS beat(4)1507.72%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-71.04%
Min Revenue beat(2)-83%
Max Revenue beat(2)-59.09%
Revenue beat(4)1
Avg Revenue beat(4)-42.18%
Min Revenue beat(4)-83%
Max Revenue beat(4)9.68%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 122.98
Fwd PE 83.02
P/S 1.97
P/FCF N/A
P/OCF N/A
P/B 0.46
P/tB 0.46
EV/EBITDA N/A
EPS(TTM)0.01
EY0.81%
EPS(NY)0.01
Fwd EY1.2%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.62
BVpS2.66
TBVpS2.65
PEG (NY)2.71
PEG (5Y)N/A
Graham Number0.77
Profitability
Industry RankSector Rank
ROA 8.02%
ROE 8.31%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 35.44%
GM 36.93%
FCFM N/A
ROA(3y)13.09%
ROA(5y)26.31%
ROE(3y)13.44%
ROE(5y)28.42%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-74.9%
OM growth 5YN/A
PM growth 3Y-36.46%
PM growth 5YN/A
GM growth 3Y-13.15%
GM growth 5Y25.4%
F-ScoreN/A
Asset Turnover0.23
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 16.53
Quick Ratio 13.29
Altman-Z 9.64
F-ScoreN/A
WACC10.11%
ROIC/WACCN/A
Cap/Depr(3y)579.46%
Cap/Depr(5y)422.67%
Cap/Sales(3y)21.87%
Cap/Sales(5y)13.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-46.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-850%
EPS Next Y45.31%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-49.15%
Revenue Next Year75.98%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-192.55%
EBIT growth 3Y-80.82%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-169.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-2836.55%
OCF growth 3YN/A
OCF growth 5YN/A

INTCHAINS GROUP LTD-ADR / ICG FAQ

Can you provide the ChartMill fundamental rating for INTCHAINS GROUP LTD-ADR?

ChartMill assigns a fundamental rating of 3 / 10 to ICG.


What is the valuation status for ICG stock?

ChartMill assigns a valuation rating of 0 / 10 to INTCHAINS GROUP LTD-ADR (ICG). This can be considered as Overvalued.


What is the profitability of ICG stock?

INTCHAINS GROUP LTD-ADR (ICG) has a profitability rating of 3 / 10.


How financially healthy is INTCHAINS GROUP LTD-ADR?

The financial health rating of INTCHAINS GROUP LTD-ADR (ICG) is 8 / 10.